200 92380 advanced:3.55891312765391 year:1.51122028428865 clipping:3.24045939653538 reason:3.55891312765391 cancer:4.63203032133495 case:0.325148690291958 part:4.02891675689965 cohort:2.32203570971108 investigators:1.68711095075232 control:0.919855798038651 design:2.29943659920322 draw:1.80971327284465 grow:0.802072762382268 study:1.94947521521981 eric:4.53974238066564 study:0.90215622093925 figure:1.80971327284465 men:2.38025813131226 follow:2.04646830498498 men:2.38025813131226 gonna:3.55891312765391 entire:3.15344801954575 biological:0.60791674794131 health:2.6957904563707 free:1.44869992730732 questionnaire:2.27105883934727 year:0.675510039073838 started:1.66806275578162 50000:3.84659520010569 levels:2.14801295573182 lorelei:4.53974238066564 1986:4.08506565095307 mucci:4.25206030821386 source:8.50412061642772 nested:2.93030446823154 nail:1.0844777777332 factors:0.867670044868081 professionals:6.88226018399506 prostate:7.69319040021138 invited:2.74798291143758 interesting:0.834333624600489 levels:1.49521994294221 remember:0.417998844255421 researchers:3.89895043043962 rimm:4.53974238066564 risk:0.614474148487469 selenium:3.84659520010569 toenails:2.54731221597543 started:1.49601108222398 study:2.96020417368935 biomarkers:1.71846235244443 talk:0.84683782344952 thought:3.84956520525888 thought:8.0578335137993 undertook:4.53974238066564 men:1.4551892245079
92380 183460 control:3.55891312765391 1987:3.24045939653538 author:0.489454245962768 case:1.28164584264415 ed:1.54401010711165 population:0.975446070875874 back:7.69319040021138 1996:1.68711095075232 nested:1.8397115960773 control:14.8356224663214 men:0.802072762382268 health:2.04646830498498 stored:3.84659520010569 study:4.9452074887738 37000:1.34789522818535 giovannucci:3.80672045060016 hypothesis:9.8904149775476 toenails:1.07400647786591 toenails:1.66806275578162 toenails:2.74798291143758 hypothesis:0.793215308548206 50000:2.72337710063538 source:5.86060893646308 ended:1.57791165878733 study:0.514390689930487 man:3.44113009199753 study:3.84659520010569 study:2.38025813131226 larry:1.17244655067916 study:1.38985942728439 back:7.69319040021138 follow:2.54731221597543 specimens:3.69244452027843 1996:2.99929733971849 professionals:2.66418375632041 toenail:16.1156670275986 clark:1.54401010711165 funds:4.53974238066564 study:0.956223442209526
183460 263310 advanced:7.11782625530782 cancer:6.1760404284466 cases:1.30059476116783 found:3.84659520010569 researchers:0.634408363388287 controls:3.6794231921546 risk:1.75236146907198 compare:2.41947884446554 specimen:0.778542264972074 health:3.06970245747747 epidemiological:1.76715365842585 37000:2.6957904563707 identified:1.83169217956343 study:4.9452074887738 toenails:1.07400647786591 1988:0.810040932031445 means:0.526366880977203 33000:0.396607654274103 trial:4.53974238066564 looked:6.80844275158845 control:5.86060893646308 number:0.307115471686182 order:1.78820706762369 cancer:0.514390689930487 men:6.88226018399506 prostate:11.5397856003171 larry:1.17244655067916 remember:0.417998844255421 toenail:1.94947521521981 find:0.634408363388287 risk:2.45789659394988 sampling:1.33708273951549 select:2.89739985461464 men:3.84659520010569 set:1.12699344128658 men:3.69244452027843 skin:2.54731221597543 study:3.69244452027843 study:1.48010208684467 cancer:0.0700101655726489 follow:12.0867502706989 clark:1.54401010711165 undertook:4.53974238066564 selenium:0.970126149671934
263310 347000 question:2.14184710786727 developing:7.11782625530782 question:3.24045939653538 question:0.550758334101362 calculate:0.550758334101362 prostate:3.0880202142233 nested:0.975446070875874 trial:1.14971829960161 study:2.32203570971108 cancer:0.634408363388287 address:2.4603008389858 authors:2.54731221597543 case:1.8397115960773 thinking:3.44113009199753 population:1.68711095075232 set:1.14971829960161 paper:2.11199414471758 risk:0.87618073453599 risk:0.748005541111992 found:1.76715365842585 highest:3.15344801954575 design:1.83169217956343 levels:2.14801295573182 estimate:0.984394319176222 60:1.47947158597407 men:3.44113009199753 measure:0.396607654274103 33000:2.69391569016731 men:2.72337710063538 conducted:2.93030446823154 odds:0.984394319176222 read:1.7263316639056 control:0.514390689930487 bit:2.80514132527753 advanced:7.69319040021138 talk:2.08144342766796 results:1.17244655067916 ratios:0.654748047625409 chance:1.52748080516043 relative:4.68503560665884 sampling:1.94947521521981 line:0.634408363388287 risk:3.68684489092481 risk:2.00562410927323 selenium:3.84659520010569 principles:0.75132896085772 sampled:2.54731221597543 critiquing:0.888061252106805 detail:0.42341891172476 questions:1.83169217956343 toenails:4.02891675689965 randomized:1.54401010711165
347000 427710 advanced:3.55891312765391 cancer:3.0880202142233 potential:0.650297380583916 exposure:2.59383223161032 categorize:2.59383223161032 case:1.49521994294221 set:1.8397115960773 diagnosed:6.67225102312648 discuss:1.9747930232041 continuous:0.725699783597694 measure:0.462204936759917 1993:5.73153189418792 relates:5.17819698992024 study:0.249282939517245 window:1.07400647786591 question:0.793215308548206 control:0.153557735843091 study:9.8904149775476 participant:7.69913041051776 question:0.582108863985438 risk:2.95894317194814 prostate:7.69319040021138 question:3.12216514150195 divided:4.53974238066564 1990:1.28164584264415 exclude:0.614474148487469 question:7.69319040021138 participant:0.37566448042886 things:2.59383223161032 measurement:0.59204083473787 selenium:0.209009040379305 equal:2.38025813131226 exposure:4.25206030821386
427710 514980 years:1.70652903660942 found:1.14971829960161 concerned:5.9243790696123 limitations:2.64262239577975 lower:1.54401010711165 larry:3.84659520010569 undertaken:1.26881672677657 core:1.92478260262944 finally:2.08300660784433 compare:3.3357695763397 exposure:4.25206030821386 men:2.41947884446554 concepts:1.43366204994278 risk:0.748005541111992 measurement:2.58909849496012 exposure:2.4390281230743 study:0.778542264972074 published:1.76715365842585 estimate:3.55891312765391 influence:2.34251780332942 happened:0.60791674794131 recently:5.84842564565943 influence:1.52748080516043 contrast:4.9452074887738 potential:1.66806275578162 randomized:1.47947158597407 measurement:1.18982296282231 secondary:2.72337710063538 compared:2.5028604534046 findings:2.95894317194814 60:3.84659520010569 study:2.38025813131226 bias:1.04072171383398 study:3.51733965203748 reflect:3.07340531187221 reflect:2.99043988588442 influence:2.34251780332942 epidemiology:2.5632916852883 relative:1.22894829697494 1996:4.02891675689965 selenium:7.69319040021138 interpretation:1.77612250421361 relates:3.07340531187221 study:9.07948476133128 20:0.485063074835967
514980 597810 advanced:3.55891312765391 agent:2.93030446823154 ago:1.70652903660942 association:2.23313218456942 placebo:2.1689555554664 based:1.00362568110411 biomarkers:3.55891312765391 blood:1.40424816473649 randomized:0.281768394661733 cancer:10.8080707497815 chemo:4.9452074887738 larry:3.84659520010569 conducted:2.54731221597543 years:3.3357695763397 data:0.231182897873627 factorial:1.14971829960161 time:2.64262239577975 epidemiological:4.83895768893108 called:3.44113009199753 published:1.02323415249249 found:3.5343073168517 states:2.64262239577975 institute:3.3357695763397 inverse:2.99929733971849 results:4.9452074887738 levels:1.07400647786591 35000:1.36168855031769 national:2.4603008389858 vitamin:2.5028604534046 potential:1.47947158597407 preventive:5.18766446322064 primary:2.38025813131226 prostate:19.2329760005284 study:2.38025813131226 diagnosis:2.34489310135832 design:1.87715455364018 recruited:3.07340531187221 studies:0.634408363388287 risk:1.84342244546241 select:2.89739985461464 selenium:26.9261664007398 specifically:1.29454924748006 united:1.41884696415764 study:1.48010208684467 thinking:1.83169217956343 cancer:0.0700101655726489 toenails:4.02891675689965 trail:4.9452074887738 trial:1.54401010711165 undertaken:4.53974238066564 undertook:4.53974238066564 men:1.70652903660942 selenium:5.99859467943698 years:0.970126149671934
597810 654100 question:2.02743675668952 forward:0.538488241509547 confounding:1.9747930232041 prostate:1.54401010711165 providing:2.86576594709396 question:0.634408363388287 study:1.9747930232041 study:2.08300660784433 explanations:1.36168855031769 randomized:1.8397115960773 study:6.88226018399506 advantages:2.99929733971849 protective:0.96552583487184 compared:4.83895768893108 found:1.87715455364018 plausible:2.38025813131226 interpretation:1.29454924748006 study:1.21951406153715 question:2.30615015915854 104:1.76715365842585 cancer:2.64262239577975 bias:1.52748080516043 questions:3.24045939653538 post:2.34251780332942 exposure:0.654748047625409 letting:1.0844777777332 concerned:3.44113009199753 answers:2.86576594709396 supplementation:2.59383223161032 prevention:3.84659520010569 evidence:3.07340531187221 logging:2.05483573087764 guess:2.08144342766796 disadvantages:2.34489310135832 relative:2.34251780332942 risk:0.614474148487469 effect:3.84659520010569 epidemiological:1.18408166947574 selenium:3.69244452027843 comments:1.92478260262944 control:1.54401010711165
